EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples | European Medicines Agency (EMA)
EMA’s human medicines committee (CHMP) has issued the first Qualification Opinion (QO) on an innovative development methodology based on artificial…
.jpg?resize=1280,670&ssl=1 "Harnessing AI and data science to discover life-changing medicines at AstraZeneca")